Literature DB >> 23227303

Fusarisetin A: Scalable Total Synthesis and Related Studies.

Jing Xu1, Eduardo J E Caro-Diaz, Michelle H Lacoske, Chao-I Hung, Colin Jamora, Emmanuel A Theodorakis.   

Abstract

Fusarisetin A (1) is a recently isolated natural product that displays an unprecedented chemical motif and remarkable bioactivities as a potent cancer migration inhibitor. We describe here our studies leading to an efficient and scalable total synthesis of 1. Essential to the strategy was the development of a new route for the formation of a trans-decalin moiety of this compound and the application of an oxidative radical cyclization (ORC) reaction that produces fusarisetin A (1) from equisetin (2) via a bio-inspired process. TEMPO-induced and metal/O(2)-promoted ORC reactions were evaluated. Biological screening in vitro confirms the reported potency of (+)-1. Importantly, ex vivo studies show that this compound is able to inhibit different types of cell migration. Moreover, the C(5) epimer of (+)-1 was also identified as a potent cancer migration inhibitor, while (-)-1 and 2 were found to be significantly less potent. The optimized synthesis is applicable on gram scale and provides a solid platform for analogue synthesis and methodical biological study.

Entities:  

Year:  2012        PMID: 23227303      PMCID: PMC3513937          DOI: 10.1039/C2SC21308G

Source DB:  PubMed          Journal:  Chem Sci        ISSN: 2041-6520            Impact factor:   9.825


  78 in total

1.  Manganese(III)-Based Oxidative Free-Radical Cyclizations.

Authors:  Barry B. Snider
Journal:  Chem Rev       Date:  1996-02-01       Impact factor: 60.622

2.  Total synthesis of (±) maoecrystal V.

Authors:  Jianxian Gong; Guang Lin; Wenbo Sun; Chuang-Chuang Li; Zhen Yang
Journal:  J Am Chem Soc       Date:  2010-11-04       Impact factor: 15.419

3.  Chemical surface modification via radical C-C bond-forming reactions.

Authors:  Kai Oliver Siegenthaler; Andreas Schäfer; Armido Studer
Journal:  J Am Chem Soc       Date:  2007-04-14       Impact factor: 15.419

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

5.  Chemistry and biology of reactive oxygen species in signaling or stress responses.

Authors:  Bryan C Dickinson; Christopher J Chang
Journal:  Nat Chem Biol       Date:  2011-07-18       Impact factor: 15.040

6.  A short stereoselective total synthesis of the fusarium toxin equisetin.

Authors:  L T Burke; D J Dixon; S V Ley; F Rodríguez
Journal:  Org Lett       Date:  2000-11-16       Impact factor: 6.005

7.  Protecting-group-free and catalysis-based total synthesis of the ecklonialactones.

Authors:  Volker Hickmann; Manuel Alcarazo; Alois Fürstner
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

Review 8.  Function-oriented synthesis, step economy, and drug design.

Authors:  Paul A Wender; Vishal A Verma; Thomas J Paxton; Thomas H Pillow
Journal:  Acc Chem Res       Date:  2007-12-27       Impact factor: 22.384

Review 9.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

10.  Cell migration and invasion assays as tools for drug discovery.

Authors:  Keren I Hulkower; Renee L Herber
Journal:  Pharmaceutics       Date:  2011-03-11       Impact factor: 6.321

View more
  11 in total

Review 1.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

2.  Illicium sesquiterpenes: divergent synthetic strategy and neurotrophic activity studies.

Authors:  Lynnie Trzoss; Jing Xu; Michelle H Lacoske; William C Mobley; Emmanuel A Theodorakis
Journal:  Chemistry       Date:  2013-03-22       Impact factor: 5.236

3.  Synthetic Strategies Toward the Decalin Motif of Maklamicin and Related Spirotetronates.

Authors:  Michelle H Lacoske; Jing Xu; Noel Mansour; Chao Gao; Emmanuel A Theodorakis
Journal:  Org Chem Front       Date:  2015-04-01       Impact factor: 5.281

4.  Fusarisetins: Structure-function studies on a novel class of cell migration inhibitors.

Authors:  Eduardo J E Caro-Diaz; Aereas Aung; Jing Xu; Shyni Varghese; Emmanuel A Theodorakis
Journal:  Org Chem Front       Date:  2014-04-01       Impact factor: 5.281

Review 5.  Radicals: Reactive Intermediates with Translational Potential.

Authors:  Ming Yan; Julian C Lo; Jacob T Edwards; Phil S Baran
Journal:  J Am Chem Soc       Date:  2016-09-26       Impact factor: 15.419

6.  A unified strategy toward total syntheses of lindenane sesquiterpenoid [4 + 2] dimers.

Authors:  Biao Du; Zhengsong Huang; Xiao Wang; Ting Chen; Guo Shen; Shaomin Fu; Bo Liu
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

Review 7.  The Biological and Chemical Diversity of Tetramic Acid Compounds from Marine-Derived Microorganisms.

Authors:  Minghua Jiang; Senhua Chen; Jing Li; Lan Liu
Journal:  Mar Drugs       Date:  2020-02-15       Impact factor: 5.118

8.  Synthesis of the tetracyclic core of Illicium sesquiterpenes using an organocatalyzed asymmetric Robinson annulation.

Authors:  Lynnie Trzoss; Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Beilstein J Org Chem       Date:  2013-06-12       Impact factor: 2.883

9.  Pyrenosetin D, a New Pentacyclic Decalinoyltetramic Acid Derivative from the Algicolous Fungus Pyrenochaetopsis sp. FVE-087.

Authors:  Bicheng Fan; Pradeep Dewapriya; Fengjie Li; Laura Grauso; Martina Blümel; Alfonso Mangoni; Deniz Tasdemir
Journal:  Mar Drugs       Date:  2020-05-26       Impact factor: 5.118

Review 10.  Natural Compounds as Target Biomolecules in Cellular Adhesion and Migration: From Biomolecular Stimulation to Label-Free Discovery and Bioactivity-Based Isolation.

Authors:  Beatrix Péter; Imre Boldizsár; Gábor M Kovács; Anna Erdei; Zsuzsa Bajtay; Alexandra Vörös; Jeremy J Ramsden; Ildikó Szabó; Szilvia Bősze; Robert Horvath
Journal:  Biomedicines       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.